Hledání článků
Filtry
Hoxha E, Thiele I, Zahner U, et al. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol 2014;25:1357–1366.
Lan PG, Johnson DW, McDonald SP, et al. The association between peritoneal dialysis modality and peritonitis. Clin J Am Soc Nephrol 2014;9:1091–1097.
Weiner DE, Tighiouart H, Ladik V, et al. Oral intradialytic nutritional suplement use and mortality in hemodialysis patients. Am J Kidney Dis 2014;63:276–285.
Zakharov S, Pelclova D, Navratil T, et al. Intermittent hemodialysis is superior to continuous veno‑venous hemodialysis/hemodiafiltraion to eliminate methanol and formate during treatment for methanol poisoning. Kidney Int 2014;86:199–207.
Dlouhodobé důsledky intermitentních a kontinuálních metod náhrady funkce ledvin u kriticky nemocných
Wald R, Shariff SZ, Adhikari NK, et al. The association between renal replacement therapy modality and long‑term outcomes among critically ill adults with acute kidney injury: a retrospective cohort study. Crit Care Med 2014;42:868–877.
Al‑Hwiesh AK, Abdul‑Rahman IS, El‑Deen MA, et al. Metformin in peritoneal dialysis: a pilot experience. Perit Dial Int 2014;34:368–375.
Eldehni MT, Odudu A, McIntyre CW. Randomized clinical trial of dialysate cooling and effects on brain white matter. J Am Soc Nephrol 2014. doi: 10.1681/ASN.2013101086
Kautz L, Jung G, Valore EV, et al. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat Genet 2014, doi:10.1038/ng.2996
Carpenter MA, John A, Weir MR, et al. Cardiovascular disease, and death in the folic acid for vascular outcome reduction in transplantation trial. J Am Soc Nephrol 2014, doi: 10.1681/ASN.2013040435
Bertoli SV, Musetti C, Ciurlino D, et al. Peritoneal ultrafiltration in refractory heart failure: a cohort study. Perit Dial Int 2014;34(1):64–70. doi: 10.3747/pdi.2012.00290